BrainsWay Launches First Clinical Trial of Deep TMS 360(TM) System for Alcohol Use Disorder
(TASE:BWAY.TA),(NasdaqGM:BWAY), BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced the launch of a multicenter clinical trial investigating the use of its novel Deep TMS 360(TM) system in individuals with Alcohol Use Disorder […]